D-0656-2026 Class II Ongoing
FDA drug recall D-0656-2026 was initiated by ACCORD HEALTHCARE, INC. on Jun 8, 2026 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 6432 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 8, 2026
- Initiation Date
- Jun 8, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6432 bottles
Product description
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.
Reason for recall
Subpotent Drug
Distribution pattern
US Nationwide.
Code information
Lot # D2401522, Exp Date: 06/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0656-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026